Jeremy Tomlinson awarded Outstanding Chief Investigator in NIHR celebration
23 July 2024
Congratulations to Professor Jeremy Tomlinson on winning an award for ‘Outstanding Chief Investigator’ from the National Institute of Health and Care Research’s (NIHR) Thames Valley and South Midlands Clinical Research Network (LCRN).
BTRU in Precision Therapeutics holds second Annual BTRU event
23 July 2024
The NIHR Blood and Translational Research Unit (BTRU) in Precision in Cellular Therapeutics had its second Annual BTRU Event on the 17 June 2024 at Edgbaston Park Hotel, University of Birmingham.
RDM Inaugural Lecture success for Professor Vanessa Ferreira
23 July 2024
On Monday 22 July, Professor Vanessa Ferreira gave her inaugural lecture titled, The investigation of cardiovascular diseases using MRI parametric mapping: The Past, Present and Future.
New study finds semaglutide (or ‘Ozempic/Wegovy’) safe for brain health with possible benefits for cognition and nicotine dependence
17 July 2024
Semaglutide – widely known as Ozempic or Wegovy – does not appear to negatively impact brain health and is associated with lower risk of cognitive problems and less nicotine dependence, according to a new study.
Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies
15 July 2024
General MRC MHU MRC WIMM Research
Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.
Senior Fellowship awarded to Costas Christodoulides
4 July 2024
Congratulations to Costas Christodoulides, who has been awarded a Senior Clinical Research Fellowship with the British Heart Foundation.
Professor Rajesh Thakker receives OBE in King’s Birthday Honours
17 June 2024
Congratulations to RDM’s Professor Rajesh Vasantlal Thakker FRS, May Professor of Medicine and lately President, Society for Endocrinology, who has been appointed Officer of the Order of the British Empire (OBE) in the King’s Birthday Honours 2024.
RDM launches new metabolism cross-cutting research theme
12 June 2024
On Monday 10 June, more than 50 members of RDM met to kick off the ‘Metabolism in Molecular Medicine’ cross-cutting research theme.
Heart scans could help thousands avoid unnecessary invasive procedure
5 June 2024
Thousands of patients admitted to hospital every year with suspected heart attacks could avoid an unnecessary invasive procedure if they have a routine heart MRI scan first, according to research led by the Radcliffe Department of Medicine.
AI analysis of routine heart scans can predict risk of a developing heart problems ten years in advance, new research finds
30 May 2024
AMIIC CVM General Publication Research
A research team led by scientists at the Radcliffe Department of Medicine, University of Oxford has developed an Artificial Intelligence (AI) technology which can accurately predict the risk of a heart attack, heart failure or cardiac death from routine cardiac CT scans, up to ten years in advance.
University of Oxford research receives £5 million funding boost from British Heart Foundation
24 May 2024
Funding will support world-leading cardiovascular disease research.
Study outlines feasibility of multiple disease risk prediction model for primary care
23 May 2024
A team of researchers, led by the Radcliffe Department of Medicine, has found that a single, integrated health check carried out in a primary care setting can accurately predict risks for diseases across multiple organs.
New Fellow of the Academy of Medical Sciences
22 May 2024
Congratulations to Professor Adam Mead, who has been elected by the Academy of Medical Sciences to its fellowship.
Congratulations to our new Associate Professors
20 May 2024
RDM is delighted to announce the conferment of three new Associate Professors. Each of our new Associate Professors has been awarded the title in recognition of their contributions to research, teaching and citizenship at the University and beyond.
Early blood glucose control for people with type 2 diabetes is crucial for reducing complications and prolonging life
18 May 2024
Research led by scientists from the Universities of Oxford and Edinburgh has found that early good blood glucose control can minimise the lifetime risk of diabetes-related complications, including heart attacks, kidney failure and vision loss.
Cancer Cell study identifies possible ways cancer treatment can lead to harmful side effects
16 May 2024
Researchers from the Simmons and Koohy Groups in the Weatherall Institute of Molecular Medicine (WIMM) Translational Immune Discovery Unit have identified potential pathways by which cancer treatment can cause colitis.